Trial Profile
Clinical Trials Insight: 700028768
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2007
Price :
$35
*
At a glance
- Drugs Iclaprim (Primary) ; Warfarin
- Indications Chlamydial infections; Embolism and thrombosis; Gonorrhoea; Nosocomial infections; Nosocomial pneumonia; Skin and soft tissue infections
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Arpida
- 26 Nov 2007 New trial record.
- 20 Nov 2007 Results have been reported.